Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.810
-0.140 (-2.83%)
At close: Aug 1, 2025, 4:00 PM
4.790
-0.020 (-0.42%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $84.93M in the quarter ending March 31, 2025, with 7,882.05% growth. This brings the company's revenue in the last twelve months to $159.49M, up 14,889.38% year-over-year. In the year 2024, Monte Rosa Therapeutics had annual revenue of $75.62M.

Revenue (ttm)
$159.49M
Revenue Growth
+14,889.38%
P/S Ratio
2.38
Revenue / Employee
$1,190,201
Employees
134
Market Cap
294.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202475.62M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings

GLUE News

More News